Annual Current Liabilities
$106.92 M
+$57.02 M+114.28%
December 31, 2024
Summary
- As of March 12, 2025, NAMS annual total current liabilities is $106.92 million, with the most recent change of +$57.02 million (+114.28%) on December 31, 2024.
- During the last 3 years, NAMS annual current liabilities has risen by +$95.73 million (+855.79%).
- NAMS annual current liabilities is now at all-time high.
Performance
NAMS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$106.92 M
+$65.66 M+159.16%
December 31, 2024
Summary
- As of March 12, 2025, NAMS quarterly total current liabilities is $106.92 million, with the most recent change of +$65.66 million (+159.16%) on December 31, 2024.
- Over the past year, NAMS quarterly current liabilities has increased by +$65.66 million (+159.16%).
- NAMS quarterly current liabilities is now at all-time high.
Performance
NAMS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NAMS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +114.3% | +159.2% |
| 3 y3 years | +855.8% | +159.2% |
| 5 y5 years | +578.7% | +159.2% |
NAMS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +855.8% | at high | +855.8% |
| 5 y | 5-year | at high | +855.8% | at high | +855.8% |
| alltime | all time | at high | +855.8% | at high | +855.8% |
NewAmsterdam Pharma Company NV Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $106.92 M(+114.3%) | $106.92 M(+159.2%) |
| Sep 2024 | - | $41.26 M(-8.9%) |
| Jun 2024 | - | $45.31 M(-24.1%) |
| Mar 2024 | - | $59.73 M(+19.7%) |
| Dec 2023 | $49.90 M | $49.90 M(+19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $41.66 M(+15.5%) |
| Dec 2022 | $36.06 M(+222.3%) | $36.06 M(+33.3%) |
| Jun 2022 | - | $27.06 M(+141.9%) |
| Dec 2021 | $11.19 M(-29.0%) | $11.19 M |
| Dec 2020 | $15.75 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual total current liabilities?
- What is the all time high annual current liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual current liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly current liabilities year-on-year change?
What is NewAmsterdam Pharma Company NV annual total current liabilities?
The current annual current liabilities of NAMS is $106.92 M
What is the all time high annual current liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual total current liabilities is $106.92 M
What is NewAmsterdam Pharma Company NV annual current liabilities year-on-year change?
Over the past year, NAMS annual total current liabilities has changed by +$57.02 M (+114.28%)
What is NewAmsterdam Pharma Company NV quarterly total current liabilities?
The current quarterly current liabilities of NAMS is $106.92 M
What is the all time high quarterly current liabilities for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly total current liabilities is $106.92 M
What is NewAmsterdam Pharma Company NV quarterly current liabilities year-on-year change?
Over the past year, NAMS quarterly total current liabilities has changed by +$65.66 M (+159.16%)